This study investigates pediatric uveitis characteristics and treatment outcomes at a local tertiary eye center, focusing on the effectiveness of biologic therapies.
A total of 37 pediatric uveitis cases were analyzed, revealing a mean onset age of 11 years, with a high incidence of bilateral (81.1%) and chronic uveitis (75.7%).
Notably, idiopathic uveitis was the most common diagnosis, and systemic conditions outlined include Behçet's disease, highlighting differences in presentation compared to other populations, particularly in treatment responses requiring immunotherapy and biologics.